We investigated risk factors for lymph node metastasis of early gastric cancer, and extended the indication of endoscopic rnucosal resection (EMR)for early gastric cancer as follows; 1) in the lesions of I type, differentiated type of mucosal cancer less than 20 mm in sire, 2) in the lesions of IIa type, differentiated type of mucosal cancer less than 40 mm in size, 3) in the lesions of IIc type, differentiated type of mucosal cancer without ulceration less than 20 mmin size, and undifferentiated type of mucosal cancer without ulceration less than 15 mm in size, and differentiated type of mucosal cancer less than 20 mm in size, associated with ulceration limit to upper third of submucosal layer. On the other hand, the indication before extending is as folloWS ;1) in the lesions of I type, differentiated type of mucosal cancer less than 20 mrn in size, 2) in the lesions of IIa type, differentiated type of mucosal cancer less than 20 mm in size, 3) in the lesions of IIc type, differentiated type of mucosal cancer without ulceration less than 10mm in size. EMR was performed with 2-channeled scope method for 251 1esions which correspond to the both indication in the last six years. We analysed the lesions, and devided them into two groups; group A) 139 1esions which correspond to the indication before extended, and group B) 112 1esions which correspond to the extended indication. The results are as follows; 1) On average, we followed up the lesions of group A for 21.5 months, and the lesions of group B for 18.7 months. 2) The rate of bleeding during EMR was 6.5%of group A, and 9.8%of group B. The rate of bleeding after EMR was 9.4%of group A, and 17.0%of group B. There was no significant difference between group A and group B. Ail of the cases of bleeding were treated by endoscopy. Perforation did not occur. 3) Concerning cancer residue, we analysed 172 1esions which were followed for more than a year. Cancer residue vvas seen in three lesions (3.2%) of group A, and in five lesions (6.5%) of group B. There was no significant difference between group A and group B. 4) Mean operation time was 30.1 minutes in group A, and 47.0 minutes in group B. We could treat all of them within 54 minutes en average. In conclusion, we considered it is possible to extend the indication of EIVIR.
View full abstract